Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey Study
These data provide insights into clozapine TDM perception, availability, TaT, and barriers. Further research is required to assess whether a faster TaT and more frequent clozapine TDM positively influence patient outcomes from a safety and effectiveness perspective.
Authors
- Kyo Bye (ORCID: https://orcid.org/0000-0001-6140-1762)
- Robert O. Cotes (ORCID: https://orcid.org/0000-0001-9903-8807)
- Megan R. Leloux (ORCID: https://orcid.org/0000-0002-5552-6160)
- K. N. Roy Chengappa (ORCID: https://orcid.org/0000-0003-1107-2854)
- Kristin Cole (ORCID: https://orcid.org/0000-0002-8783-0191)
- Matej Markota (ORCID: https://orcid.org/0000-0002-0437-5497)
- Georgios Schoretsanitis (ORCID: https://orcid.org/0000-0002-3851-4117)
- Jessica M. Gannon (ORCID: https://orcid.org/0000-0003-0762-4054)
- Nicholas D. Allen (ORCID: https://orcid.org/0000-0003-4009-186X)
- Jonathan G. Leung (ORCID: https://orcid.org/0000-0003-3836-9375)
- Morgan Gatzlaff
Institutions
- Northwell Health (US)
- Mayo Clinic (US)
- Hofstra University (US)
- Emory University (US)
- University of Pittsburgh (US)
- University of Zurich (CH)
- Western Pennsylvania Hospital (US)
- Santa Barbara Cottage Hospital (US)
- University Hospital of Zurich (CH)
- Mayo Clinic in Arizona (US)
- University of Pittsburgh Medical Center (US)
- Mayo Clinic in Florida (US)
- Zucker Hillside Hospital (US)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1097/ftd.0000000000001415
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00